adenylate kinase/breast neoplasms

Lyen an sove nan clipboard la

Chwazi kalite sòt

5 rezilta yo

Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m ⁶ A-Based Epitranscriptomic Mechanism

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

N⁶-methyladenosine (m⁶A) is the most abundant internal modification in mRNA and this methylation constitutes an important regulatory mechanism for the stability and translational efficiency of mRNA. In this study, we found that the protein levels of adenylate kinase 4 (AK4) and

31P-NMR studies of phosphate transfer rates in T47D human breast cancer cells.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The concentration of phosphates and the kinetics of phosphate transfer reactions were measured in the human breast cancer cell line, T47D, using 31P-NMR spectroscopy. The cells were embedded in agarose filaments and perifused with oxygenated medium during the NMR measurements. The following

Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The adenylate kinase (AK) isoforms network plays an important role in the intracellular energy transfer processes, the maintenance of energy homeostasis, and it is a major player in AMP metabolic signaling circuits in some highly-differentiated cells. For this purpose, a rapid and sensitive method

AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Breast cancer (BC) is a type of malignant tumor originating from the epithelial tissue of the mammary gland, and about 20% of breast cancers are human epidermal growth factor receptor 2 positive (HER2+), which is a subtype with more aggression. Recently, HER2-positive breast cancer is often

Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Extracellular adenosine mediates diverse anti-inflammatory, angiogenic and vasoactive effects and becomes an important therapeutic target for cancer, which has been translated into clinical trials. This study was designed to comprehensively assess adenosine metabolism in prostate and breast cancer

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

adenylate kinase/breast neoplasms

Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m 6 A-Based Epitranscriptomic Mechanism

31P-NMR studies of phosphate transfer rates in T47D human breast cancer cells.

Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.

AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.

Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia.

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m ⁶ A-Based Epitranscriptomic Mechanism